Regulatory status
Humanin is an unapproved research compound. It has no FDA-approved label, no approved indications, and no approved brand name.
What humanin is
Humanin is a peptide with the molecular formula C119H204N34O32S2 and a molecular weight of about 2,687 g/mol (PubChem CID 16131438). Because no regulatory label exists for this compound, there is no established mechanism of action, drug class, or approved use to report.
Trial footprint
Seven trials referencing humanin are registered. The available studies are largely observational rather than interventional. One recruiting trial is examining humanin and MOTS-c levels alongside ferroptosis markers during renal transplantation under different anesthesia approaches. Another recruiting study looks at high-intensity physical exercise in people with dialyzed or conservatively managed chronic kidney disease. A third trial, with an unknown status, is evaluating humanin's value for early diagnosis and short-term prognosis in acute kidney injury following heart transplantation. These studies focus on measuring humanin levels in specific clinical contexts rather than testing humanin as a treatment.